Página principal > Resultados de la búsqueda: Drugs
  Consejos para la búsqueda
Búsqueda avanzada
Buscar colecciones:
Ordenar por: Mostrar resultados: Formato de visualización:
Depósito Digital de Documentos de la UAB Encontrados 27 registros  1 - 10siguientefinal  ir al registro: La búsqueda tardó 0.01 segundos. 
1.
10 p, 1.4 MB Cultural stigmatization and police corruption : cannabis, gender, and legalization in Mexico / Fondevila, Gustavo (Centro de Investigación y Docencia Económicas (México)) ; Agoff, Carolina (Universidad Nacional Autónoma de México) ; Sandberg, Sveinung (University of Oslo)
Mexico may well be the largest country in the world to legalize cannabis. Nevertheless, it is culturally conservative and a certain discrepancy exists between liberalization reforms and popular opinion regarding cannabis. [...]
2022 - 10.1080/09687637.2021.2004089
Drugs: Education, Prevention and Policy, Vol. 29 Núm. 4 (2022) , p. 373-381  
Registro completo - Creative Commons
2.
11 p, 992.2 KB Educational Impact on Apixaban Adherence in Atrial Fibrillation (the AEGEAN STUDY) : A Randomized Clinical Trial / Montalescot, Gilles (Centre Hospitalier Universitaire Pitié-Salpêtriėre) ; Brotons, Carlos (Institut d'Investigació Biomèdica Sant Pau) ; Cosyns, Bernard (Universitair Ziekenhuis Brussel) ; Crijns, Harry J. (Maastricht University Medical Centre) ; D'Angelo, Armando (Scientific Institute San Raffaele) ; Drouet, Ludovic (Paris Diderot University) ; Eberli, Franz R. (Stadtspital Triemli) ; Lane, Deirdre (University of Liverpool and Liverpool Heart & Chest Hospital) ; Besse, Bruno (Bristol-Myers Squibb) ; Chan, Anthony (Pfizer Healthcare Ireland) ; Vicaut, Eric (Centre Hospitalier Universitaire Lariboisière (AP-HP)) ; Darius, Harald (Vivantes Neukoelln Medical Center) ; Universitat Autònoma de Barcelona
Adherence to non-vitamin-K oral anticoagulants (NOACs) may be lower than to vitamin K antagonists because NOACs do not require routine monitoring. We assessed the impact of an educational program on adherence and persistence with apixaban in patients with non-valvular atrial fibrillation (NVAF). [...]
2020 - 10.1007/s40256-019-00356-2
American Journal of Cardiovascular Drugs, Vol. 20 Núm. 1 (january 2020) , p. 61-71  
Registro completo - Creative Commons
3.
37 p, 16.6 MB Marine Invertebrates : A Promissory Still Unexplored Source of Inhibitors of Biomedically Relevant Metallo Aminopeptidases Belonging to the M1 and M17 Families / Pascual Alonso, Isel (University of Havana. Center for Protein Studies) ; Almeida García, Fabiola (University of Havana. Center for Protein Studies) ; Valdés Tresanco, Mario Ernesto (University of Calgary. Department of Biological Sciences) ; Arrebola Sánchez, Yarini (University of Havana. Center for Protein Studies) ; Ojeda del Sol, Daniel (University of Havana. Center for Protein Studies) ; Sánchez Ramírez, Belinda (Centro de Inmunología Molecular) ; Florent, Isabelle (Muséum National d'Histoire Naturelle) ; Schmitt, Marjorie (Université de Strasbourg) ; Avilés, Francesc X. (Universitat Autònoma de Barcelona. Institut de Biotecnologia i de Biomedicina "Vicent Villar Palasí") ; Universitat Autònoma de Barcelona. Departament de Bioquímica i de Biologia Molecular
Proteolytic enzymes, also known as peptidases, are critical in all living organisms. Peptidases control the cleavage, activation, turnover, and synthesis of proteins and regulate many biochemical and physiological processes. [...]
2023 - 10.3390/md21050279
Marine drugs, Vol. 21, Issue 5 (April 2023) , art. 279  
Registro completo - Creative Commons
4.
9 p, 943.8 KB Pharmacological Management of Borderline Personality Disorder and Common Comorbidities / Pascual Mateos, Juan Carlos (Institut d'Investigació Biomèdica Sant Pau) ; Arias, Laia (Institut d'Investigació Biomèdica Sant Pau) ; Soler, Joaquim (Institut d'Investigació Biomèdica Sant Pau) ; Universitat Autònoma de Barcelona
Comorbidity between borderline personality disorder (BPD) and other mental disorders is common. Although no specific pharmacological treatments have been approved for the treatment of BPD, many drugs, including antidepressants such as selective serotonin reuptake inhibitors (SSRIs), mood stabilizers, second-generation antipsychotics, and even benzodiazepines, are routinely prescribed off label. [...]
2023 - 10.1007/s40263-023-01015-6
CNS Drugs, Vol. 37 (may 2023) , p. 489-497  
Registro completo - Creative Commons
5.
15 p, 873.6 KB Immunoregulatory and/or Anti-inflammatory Agents for the Management of Core and Associated Symptoms in Individuals with Autism Spectrum Disorder : A Narrative Review of Randomized, Placebo-Controlled Trials / Arteaga-Henríquez, Gara (Hospital Universitari Vall d'Hebron. Institut de Recerca) ; Gisbert-Gustemps, Laura (Hospital Universitari Vall d'Hebron. Institut de Recerca) ; Ramos-Quiroga, Josep Antoni (Hospital Universitari Vall d'Hebron. Institut de Recerca) ; Universitat Autònoma de Barcelona
Autism spectrum disorder (ASD) is a heterogeneous neurodevelopmental condition with a so far poorly understood underlying pathogenesis, and few effective therapies for core symptoms. Accumulating evidence supports an association between ASD and immune/inflammatory processes, arising as a possible pathway for new drug intervention. [...]
2023 - 10.1007/s40263-023-00993-x
CNS Drugs, Vol. 37 (march 2023) , p. 215-229  
Registro completo - Creative Commons
6.
17 p, 3.1 MB Isolation and Characterization of NpCI, a New Metallocarboxypeptidase Inhibitor from the Marine Snail Nerita peloronta with Anti- Plasmodium falciparum Activity / Cabrera-Muñoz, Aymara (Universidad de la Habana. Centro de Estudio de Proteínas) ; Sierra-Gómez, Yusvel (Universidad de la Habana. Centro de Estudio de Proteínas) ; Covaleda Cortés, Giovanni (Universitat Autònoma de Barcelona. Departament de Bioquímica i de Biologia Molecular) ; Reytor, Mey L. (Universidad de la Habana. Centro de Estudio de Proteínas) ; González-González, Yamile (Universidad de la Habana. Centro de Estudio de Proteínas) ; Bautista, José M. (Universidad Complutense de Madrid. Departamento de Bioquímica y Biología Molecular) ; Avilés, Francesc X. (Universitat Autònoma de Barcelona. Departament de Bioquímica i de Biologia Molecular) ; Alonso del Rivero, Maday (Universidad de la Habana. Centro de Estudio de Proteínas)
Metallocarboxypeptidases are zinc-dependent peptide-hydrolysing enzymes involved in several important physiological and pathological processes. They have been a target of growing interest in the search for natural or synthetic compound binders with biomedical and drug discovery purposes, i. [...]
2023 - 10.3390/md21020094
Marine drugs, Vol. 21 (january 2023)  
Registro completo - Creative Commons
7.
20 p, 189.2 KB LDL Cholesterol Reduction Variability with Different Types and Doses of Statins in Monotherapy or Combined with Ezetimibe. Results from the Spanish Arteriosclerosis Society Dyslipidaemia Registry / Climent, Elisenda (Universitat Autònoma de Barcelona. Departament de Medicina) ; Bea Sanz, Ana Maria (Hospital Universitario Miguel Servet (Saragossa)) ; Benaiges, David (Institut Hospital del Mar d'Investigacions Mèdiques) ; Brea-Hernando, Ángel (Hospital San Pedro, Logroño) ; Pintó, Xavier (Hospital Universitari de Bellvitge) ; Suarez Tembra, Manuel (Hospital San Rafael, A Coruña) ; Perea, Verónica (Hospital Universitari MútuaTerrassa (Terrassa, Catalunya)) ; Plana, Núria (Hospital Universitari Sant Joan de Reus (Tarragona)) ; Blanco Vaca, Francisco (Universitat Autònoma de Barcelona. Departament de Bioquímica i de Biologia Molecular) ; Pedro-Botet, Juan (Universitat Autònoma de Barcelona. Departament de Medicina)
Purpose: Low-density lipoprotein (LDL) cholesterol reduction by statin therapy is dose-dependent, varies among different statins, and has wide inter-individual variability. The present study aimed to compare mean LDL cholesterol reduction and its variability achieved with different doses of the three statins most frequently used in monotherapy or combined with ezetimibe in a real clinical setting. [...]
2022
Cardiovascular Drugs and Therapy, Vol. 36 Núm. 2 (2022) , p. 301-308  
Registro completo -
8.
18 p, 2.0 MB Insights into the light response of skeletonema marinoi : Involvement of ovothiol / Milito, Alfonsina (Centre de Recerca en Agrigenòmica) ; Orefice, Ida (Stazione Zoologica Anton Dohrn. Department of Marine Biotechnology) ; Smerilli, Arianna (Stazione Zoologica Anton Dohrn. Department of Marine Biotechnology) ; Castellano, Immacolata (Stazione Zoologica Anton Dohrn. Department of Biology and Evolution of Marine Organisms) ; Napolitano, Alessandra (University of Naples "Federico II". Department of Chemical Sciences) ; Brunet, Christophe (Stazione Zoologica Anton Dohrn. Department of Marine Biotechnology) ; Palumbo, Anna (Stazione Zoologica Anton Dohrn. Department of Biology and Evolution of Marine Organisms)
Diatoms are one of the most widespread groups of microalgae on Earth. They possess extraordinary metabolic capabilities, including a great ability to adapt to different light conditions. Recently, we have discovered that the diatom Skeletonema marinoi produces the natural antioxidant ovothiol B, until then identified only in clams. [...]
2020 - 10.3390/md18090477
Marine drugs, Vol. 18, Núm. 9 (September 2020) , art. 477  
Registro completo - Creative Commons
9.
12 p, 1.1 MB REal worlD Effectiveness and Safety of Mepolizumab in a Multicentric Spanish Cohort of Asthma Patients Stratified by Eosinophils : The REDES Study / Domingo, Christian (Parc Taulí Hospital Universitari. Institut d'Investigació i Innovació Parc Taulí (I3PT)) ; Carrillo Díaz, Teresa (Universidad de Las Palmas de Gran Canaria) ; Blanco Aparicio, Marina (H. Universitario A Coruña) ; Martínez Moragón, Eva (H. Universitario Doctor Peset, Valencia) ; Bañas-Conejero, David (GlaxoSmithKline. Specialty Care Medical Department) ; Sánchez Herrero, M. Guadalupe (GlaxoSmithKline. Specialty Care Medical Department) ; Universitat Autònoma de Barcelona. Departament de Medicina
The efficacy of mepolizumab is well documented in severe eosinophilic asthma (SEA), although the stringent selection criteria adopted by SEA clinical trials limits the generalizability of results. Our study evaluated the effectiveness and safety of mepolizumab in patients with SEA in Spain. [...]
2021 - 10.1007/s40265-021-01597-9
Drugs, Vol. 81 (september 2021) , p. 1763-1774
2 documentos
Registro completo - Creative Commons
10.
10 p, 751.6 KB Vaccinations in Patients Receiving Systemic Drugs for Skin Disorders : What Can We Learn for SARS-Cov-2 Vaccination Strategies? / Speeckaert, Reinhart (Universitair Ziekenhuis Gent) ; Lambert, Jo (Universitair Ziekenhuis Gent) ; Puig Sanz, Lluís (Institut d'Investigació Biomèdica Sant Pau) ; Speeckaert, Marijn (Universitair Ziekenhuis Gent) ; Lapeere, Hilde (Universitair Ziekenhuis Gent) ; De Schepper, Sofie (Universitair Ziekenhuis Gent) ; van Geel, Nanja (Universitair Ziekenhuis Gent) ; Universitat Autònoma de Barcelona
Large-scale vaccination strategies are currently being deployed against severe acute respiratory syndrome coronavirus-2 (SARS-Cov-2). Whether systemic medication for skin diseases affects the efficacy of vaccination and whether temporary interruption or extension of the dosing interval is necessary is under debate. [...]
2021 - 10.1007/s40268-021-00349-0
Drugs in R&D, june 2021, p. 1-10  
Registro completo - Creative Commons

Depósito Digital de Documentos de la UAB : Encontrados 27 registros   1 - 10siguientefinal  ir al registro:
¿Le interesa recibir alertas sobre nuevos resultados de esta búsqueda?
Defina una alerta personal vía correo electrónico o subscríbase al canal RSS.
Depósito Digital de Documentos de la UAB :: Buscar :: Enviar :: Personalizar :: Ayuda
Powered by Invenio v1.1.6
Mantenido por ddd.bib@uab.cat  :: Metadatos sujetos a:
Colaboramos